awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q58562101-A3BCDE29-D245-49BE-A6CA-226D7E36CF61
Q58562101-A3BCDE29-D245-49BE-A6CA-226D7E36CF61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58562101-A3BCDE29-D245-49BE-A6CA-226D7E36CF61
Linking cellular metabolism and metabolomics to risk-stratification of prostate cancer clinical aggressiveness and potential therapeutic pathways
P2860
Q58562101-A3BCDE29-D245-49BE-A6CA-226D7E36CF61
BestRank
Statement
http://www.wikidata.org/entity/statement/Q58562101-A3BCDE29-D245-49BE-A6CA-226D7E36CF61
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f40cf6b368f053ca413ad4a202182270a34e0d6
P2860
Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors.